Webinar
A Clinical Leader conversation with Craig Lipset and Dr. Derk Arts. Watch the full recording on demand.
The industry approves roughly 50 new medicines in a strong year. Researchers characterize 150 to 250 new rare diseases in that same time. With more than 10,000 rare diseases on the books, patient organizations are no longer waiting to be invited into research. They are sponsoring it. Craig Lipset and Dr. Derk Arts trace how patient groups move from advisory voices to the drivers of drug development, how small populations can still generate real evidence, and who should own the data these studies run on.
See how Castor Catalyst helps patient organizations, academics, and sponsors build natural history studies and registries with AI-assisted data extraction and human review.
Explore Castor CatalystDiscover all the features offered by Castor EDC
Discover Now